Home › Chronic Myelomonocytic Leukemia › Texas › Houston

Pag-aaral pangklinika para sa Chronic Myelomonocytic Leukemia sa Houston, TX

16 pag-aaral para sa Chronic Myelomonocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Houston (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

Nagre-recruitPhase 2

The University of Texas MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 15, 2026 · NCT04996875

Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT03683433

A Phase 2 Study Evaluating Olutasidenib in Patients With IDH1-mutated Clonal Cytopenia of Undetermined Significance and Lower-risk Myelodysplastic/Syndromes/Chronic Myelomonocytic Leukemia.

Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06566742

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT03383575

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

Nagre-recruitPhase 2

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07033598

Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS

Nagre-recruitPhase 2/3Malugod na tinatanggap ang malusog na boluntaryo

M D Anderson Cancer Center, Houston

Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT04708054

Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances

Nagre-recruitPhase 1/2

M D Anderson Cancer Center, Houston

Edad 12 hanggang 80 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT05092451

Personalized NK Cell Therapy in CBT

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 15 hanggang 80 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT02727803

Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)

Nagre-recruitPhase 1/2

The University of Texas M. D. Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT07128381

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Nagre-recruitPhase 2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT04239157

CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Nagre-recruitPhase 1

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update May 20, 2026 · NCT03896269

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Nagre-recruitPhase 1/2

M D Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT04140487

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2

MD Anderson, Houston

Edad 18 hanggang 66 · Lahat ng kasarian · Na-update Mar 17, 2026 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 12 pataas · Lahat ng kasarian · Na-update Mar 16, 2026 · NCT06994676

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

Nagre-recruitPhase 1

MD Anderson Cancer Center, Houston

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT06950034

Pag-aaral para sa Chronic Myelomonocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Houston

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.